(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(3,5-DICHLOROPHENYL)PROPANOIC ACID, 95.0%, 100mg

1-Methyl-1H-pyrazol-5-ol, 95.0%, 100g

5,5-Dimethyl-1,3-dioxan-2-one, 95%, 10g

N,N-Diethylaminotrimethylsilane, 100g

4-oxo-1,4-dihydroquinazoline-2-carbohydrazide, 98%, 10g

1,1,2,2-Tetrafluoroethyl-2,2,3,3-tetrafluoropropyl ether, 98.0%, 25g

Chymotrypsine, 500 mg

3,4-Dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 95.0%, 1g

tert-Butyl (1R*,4R*)-4-(4-bromobenzamido)cyclohexylcarbamate, 1g

(5-(Methoxycarbonyl)thiophen-3-yl)boronic acid, 95.0%, 1g

1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one hydrochloride, 98.0%, 5g

5-Amino-1-(3-chlorophenyl)-1H-pyrazole-4-carbonitrile, 95.0%, 5g

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,3-dihydro-1H-indene-2-carboxylic acid, 95.0%, 250mg